Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert L Atmar

Showing results (151-160 of 261) with videos related to

Pageof 27
Sort By:
The Journal of Infectious Diseases|June 22, 2014
A novel intramuscular bivalent norovirus virus-like particle vaccine candidate--reactogenicity, safety, and immunogenicity in a phase 1 trial in healthy adultsJohn J Treanor, Robert L Atmar, Sharon E Frey, et al.
Journal of Clinical Microbiology|November 16, 2007
Sequential outbreaks of infections by distinct Acinetobacter baumannii strains in a public teaching hospital in Houston, TexasSamuel A Shelburne, Kavindra V Singh, A Clinton White, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 10, 2006
Safety and immunogenicity of nonadjuvanted and MF59-adjuvanted influenza A/H9N2 vaccine preparationsRobert L Atmar, Wendy A Keitel, Shital M Patel, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 7, 2014
Plasmid-based human norovirus reverse genetics system produces reporter-tagged progeny virus containing infectious genomic RNAKazuhiko Katayama, Kosuke Murakami, Tyler M Sharp, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 21, 2016
Structural basis for norovirus neutralization by an HBGA blocking human IgA antibodySreejesh Shanker, Rita Czakó, Gopal Sapparapu, et al.
Vaccine|July 18, 2009
Contrasting effects of type I interferon as a mucosal adjuvant for influenza vaccine in mice and humansRobert B Couch, Robert L Atmar, Thomas R Cate, et al.
Biorxiv : the Preprint Server for Biology|July 15, 2025
Overcoming host restrictions to enable continuous passaging of human noroviruses in human intestinal enteroidsGurpreet Kaur, Sue Crawford, Sasirekha Ramani, et al.
Vaccine|December 3, 2014
Robust mucosal-homing antibody-secreting B cell responses induced by intramuscular administration of adjuvanted bivalent human norovirus-like particle vaccineAarthi Sundararajan, Mark Y Sangster, Sharon Frey, et al.
MMWR. Recommendations and Reports : Morbidity and Mortality Weekly Report. Recommendations and Reports|December 14, 2019
Use of Anthrax Vaccine in the United States: Recommendations of the Advisory Committee on Immunization Practices, 2019William A Bower, Jarad Schiffer, Robert L Atmar, et al.
Viruses|September 11, 2019
Human Norovirus Histo-Blood Group Antigen (HBGA) Binding Sites Mediate the Virus Specific Interactions with Lettuce CarbohydratesMalak A Esseili, Xiang Gao, Patricia Boley, et al.
Pageof 27

Showing results (151-160 of 261) with videos related to

Sort By:
Pageof 27
The Journal of Infectious Diseases|June 22, 2014
A novel intramuscular bivalent norovirus virus-like particle vaccine candidate--reactogenicity, safety, and immunogenicity in a phase 1 trial in healthy adultsJohn J Treanor, Robert L Atmar, Sharon E Frey, et al.
Journal of Clinical Microbiology|November 16, 2007
Sequential outbreaks of infections by distinct Acinetobacter baumannii strains in a public teaching hospital in Houston, TexasSamuel A Shelburne, Kavindra V Singh, A Clinton White, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 10, 2006
Safety and immunogenicity of nonadjuvanted and MF59-adjuvanted influenza A/H9N2 vaccine preparationsRobert L Atmar, Wendy A Keitel, Shital M Patel, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 7, 2014
Plasmid-based human norovirus reverse genetics system produces reporter-tagged progeny virus containing infectious genomic RNAKazuhiko Katayama, Kosuke Murakami, Tyler M Sharp, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 21, 2016
Structural basis for norovirus neutralization by an HBGA blocking human IgA antibodySreejesh Shanker, Rita Czakó, Gopal Sapparapu, et al.
Vaccine|July 18, 2009
Contrasting effects of type I interferon as a mucosal adjuvant for influenza vaccine in mice and humansRobert B Couch, Robert L Atmar, Thomas R Cate, et al.
Biorxiv : the Preprint Server for Biology|July 15, 2025
Overcoming host restrictions to enable continuous passaging of human noroviruses in human intestinal enteroidsGurpreet Kaur, Sue Crawford, Sasirekha Ramani, et al.
Vaccine|December 3, 2014
Robust mucosal-homing antibody-secreting B cell responses induced by intramuscular administration of adjuvanted bivalent human norovirus-like particle vaccineAarthi Sundararajan, Mark Y Sangster, Sharon Frey, et al.
MMWR. Recommendations and Reports : Morbidity and Mortality Weekly Report. Recommendations and Reports|December 14, 2019
Use of Anthrax Vaccine in the United States: Recommendations of the Advisory Committee on Immunization Practices, 2019William A Bower, Jarad Schiffer, Robert L Atmar, et al.
Viruses|September 11, 2019
Human Norovirus Histo-Blood Group Antigen (HBGA) Binding Sites Mediate the Virus Specific Interactions with Lettuce CarbohydratesMalak A Esseili, Xiang Gao, Patricia Boley, et al.
Pageof 27